Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Revance Therapeutics, Inc. (RVNC)  
$2.70 0.20 (6.9%) as of 4:30 Fri 6/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 82,270,000
Market Cap: 222.13(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.67 - $31.13
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 8.1
Insider 3/6 Months : 8.7
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Revance Therapeutics is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. Co.'s segments are: Product, which refers to the business that includes the research, development and commercialization of its product candidates and the RHA® Collection of dermal fillers; and Service, which refers to the business that includes the development and commercialization of the OPUL™ Relational Commerce Platform and HintMD platform.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 30,000 30,000 30,000
Total Buy Value $0 $209,400 $209,400 $209,400
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 1 1
Total Shares Sold 29,089 29,089 154,480 446,160
Total Sell Value $143,717 $143,717 $3,162,442 $12,719,522
Total People Sold 4 4 5 5
Total Sell Transactions 4 4 11 27
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 397
  Page 16 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-12-09 4 AS $18.00 $9,000 D/D (500) 14,106     -
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-12-09 4 OE $2.55 $1,275 D/D 500 14,606     -
   Browne L Daniel CEO and President   •       •      –    2014-11-28 4 B $16.67 $100,019 D/D 6,000 172,626 2.81     -
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-11-18 4 AS $16.00 $16,000 D/D (1,000) 14,106     -
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-11-18 4 OE $2.55 $2,550 D/D 1,000 15,106     -
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-10-28 4 AS $20.00 $10,000 D/D (500) 13,268     -
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-10-28 4 OE $2.55 $1,275 D/D 500 13,768     -
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-10-17 4 AS $18.50 $27,839 D/D (1,500) 13,268     -
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-10-17 4 OE $2.55 $3,825 D/D 1,500 14,768     -
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-09-17 4 AS $20.50 $41,098 D/D (2,000) 13,268     -
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-09-17 4 OE $2.55 $2,963 D/D 1,162 15,268     -
   Byrnes Robert F Director   –       •      –    2014-09-17 4 GA $0.00 $0 I/I 2,666 2,666     -
   Byrnes Robert F Director   –       •      –    2014-09-17 4 GD $0.00 $0 D/D 2,666 0     -
   Byrnes Robert F Director   –       •      –    2014-09-17 4 OE $3.60 $9,598 D/D 2,666 2,666     -
   Waugh Jacob Chief Scientific Officer   •       –      –    2014-09-17 4 AS $20.58 $2,025,441 D/D (97,713) 25,000     -
   Waugh Jacob Chief Scientific Officer   •       –      –    2014-09-17 4 OE $2.55 $538,386 D/D 69,380 122,713     -
   Bertolino Arthur Peter EVP and Chief Medical Officer   •       –      –    2014-09-02 4 A $0.00 $0 D/D 39,375 39,375     -
   Waugh Jacob Chief Scientific Officer   •       –      –    2014-08-18 4 S $24.47 $611,675 D/D (25,000) 53,333     -
   Waugh Jacob Chief Scientific Officer   •       –      –    2014-05-19 4 A $32.22 $805,500 D/D 25,000 78,333     -
   Browne L Daniel CEO and President   •       •      –    2014-05-19 4 A $32.22 $3,093,120 D/D 96,000 166,626     -
   Ruegg Curtis EVP R&D and Tech Operations   •       –      –    2014-05-19 4 A $32.22 $338,310 D/D 10,500 14,106     -
   Silvernail Lauren P CFO, Seretary & EVP Corp Dev.   •       –      –    2014-05-19 4 A $32.22 $451,080 D/D 14,000 14,000     -
  397 Records found
  Previous  10  11  12  13  14  15  16    
  Page 16 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us